Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy

Zhou, L; Yang, Y; Si, L; Chi, ZH; Sheng, XN; Lian, B; Wang, X; Tang, BX; Mao, LL; Yan, XQ; Li, SM; Bai, X; Guo, J; Cui, CL

Cui, CL (通讯作者)，Peking Univ, Canc Hosp & Inst, Dept Renal Canc & Melanoma, Beijing 100142, Peoples R China.

MELANOMA RESEARCH, 2022; 32 (3): 142

Abstract

Treatment for advanced melanoma after progression on immunotherapy is limited. This phase II trial (NCT03422445) was conducted to evaluate the efficac......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索